Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current assets
Cash	$ 6,380,782	$ 8,538,270
Marketable equity securities, at fair value	1,914,785	1,892,837
Prepaid expenses	189,689	93,972
Note receivable - current	50,000	50,000
Total current assets	8,535,256	10,575,079
Investment in joint ventures at fair value	410,000	410,000
Total assets	8,945,256	10,985,079
Current liabilities
Accounts payable	699,811	360,964
Accrued expenses	45,952	426,823
Accrued license fee - current portion	80,000	80,000
Total current liabilities	825,763	867,787
Accrued license fee - less current portion	235,000	235,000
Total liabilities	1,060,763	1,102,787
Commitments and contingencies
Stockholders’ equity
Preferred stock value
Common stock, $0.0001 par value, 75,000,000 shares authorized, 23,975,098 and 23,974,546 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively	2,398	2,398
Additional paid-in-capital	44,166,909	43,589,471
Accumulated deficit	(36,298,670)	(33,727,163)
Accumulated other comprehensive gain	13,856	17,586
Total stockholders’ equity	7,884,493	9,882,292
Total liabilities and stockholders’ equity	8,945,256	10,985,079
Series A Convertible Preferred Stock
Stockholders’ equity
Preferred stock value